CLEARANCE OF ATRACURIUM AND LAUDANOSINE IN THE URINE AND BY CONTINUOUS VENOVENOUS HEMOFILTRATION

被引:19
作者
SHEARER, ES
OSULLIVAN, EP
HUNTER, JM
机构
[1] University Department of Anaesthesia, Royal Liverpool Hospital, Liverpool L69 3BX, Prescot Street
关键词
INTENSIVE CARE; HEMOFILTRATION; KIDNEY; URINARY CLEARANCE; LAUDANOSINE; NEUROMUSCULAR RELAXANTS; ATRACURIUM;
D O I
10.1093/bja/67.5.569
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We have measured the steady state urinary clearances of atracurium, given by constant infusion, and laudanosine in eight patients undergoing artificial ventilation; all had normal renal function (mean creatinine clearance 81 ml min-1). Mean (SD) urinary clearance of atracurium was 0.55 (0.5) ml kg-1 min-1; that of laudanosine was 0.33 (0.2) ml kg-1 min-1. Simultaneous plasma clearances were 7.1 (1.4) ml kg-1 min-1 and 3.8 (1.5) ml kg-1 min-1, respectively. Notional haemofiltration clearances of the two substances were measured also in seven critically ill patients with renal and respiratory failure undergoing continuous venovenous haemofiltration. Mean (SD) clearances of atracurium and laudanosine in the haemofiltrate fluid were 0.11 (0.06) ml kg-1 min-1 and 0.09 (0.02) ml kg-1 min-1, respectively whilst plasma clearances were atracurium 6.7 (1.8) ml kg-1 min-1 and laudanosine 4.5 (1.8) ml kg-1 min-1. There were no significant differences between the plasma clearances of the drugs in the two groups, despite the difference in severity of sickness. Urinary clearance rates of atracurium and laudanosine were approximately 8 and 9% of that in the plasma, but the haemofiltration clearance of both substances was only 2%.
引用
收藏
页码:569 / 573
页数:5
相关论文
共 15 条
[1]  
BENOWITZ N, 1974, CLIN PHARMACOL THER, V16, P99
[2]   IV FLUIDS DURING SURGERY [J].
CAMPBELL, IT ;
BAXTER, JN ;
TWEEDIE, IE ;
TAYLOR, GT ;
KEENS, SJ .
BRITISH JOURNAL OF ANAESTHESIA, 1990, 65 (05) :726-729
[3]   EFFECTS OF ANAESTHESIA WITH THIOPENTONE, NITROUS OXIDE, NARCOTICS AND NEUROMUSCULAR BLOCKING DRUGS ON RENAL FUNCTION IN NORMAL MAN [J].
DEUTSCH, S ;
BASTRON, RD ;
PIERCE, EC ;
VANDAM, LD .
BRITISH JOURNAL OF ANAESTHESIA, 1969, 41 (10) :807-&
[4]   ELIMINATION OF ATRACURIUM IN HUMANS - CONTRIBUTION OF HOFMANN ELIMINATION AND ESTER HYDROLYSIS VERSUS ORGAN-BASED ELIMINATION [J].
FISHER, DM ;
CANFELL, PC ;
FAHEY, MR ;
ROSEN, JI ;
RUPP, SM ;
SHEINER, LB ;
MILLER, RD .
ANESTHESIOLOGY, 1986, 65 (01) :6-12
[5]  
FOLDES FF, 1983, BRIT J ANAESTH, V55, P315
[6]  
GOLPER TA, 1985, INT J ARTIF ORGANS, V8, P307
[7]   REMOVAL OF THERAPEUTIC DRUGS BY CONTINUOUS ARTERIOVENOUS HEMOFILTRATION [J].
GOLPER, TA ;
PULLIAM, J ;
BENNETT, WM .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (09) :1651-1652
[8]  
KELLER F, 1983, CLIN NEPHROL, V19, P201
[9]   PHARMACOKINETICS OF ATRACURIUM AND LAUDANOSINE IN THE ELDERLY [J].
KENT, AP ;
PARKER, CJR ;
HUNTER, JM .
BRITISH JOURNAL OF ANAESTHESIA, 1989, 63 (06) :661-666
[10]   METABOLIC STUDIES IN THE CAT WITH ATRACURIUM - A NEUROMUSCULAR BLOCKING-AGENT DESIGNED FOR NON-ENZYMIC INACTIVATION AT PHYSIOLOGICAL PH [J].
NEILL, EAM ;
CHAPPLE, DJ .
XENOBIOTICA, 1982, 12 (03) :203-210